ReNeuron Group plc announced that Dr. Richard Beckman has joined the company as chief medical officer. He replaces Dr. Julian Howell who has left the company to pursue another opportunity. Dr. Beckman brings to ReNeuron more than 25 years of executive and consultancy experience in drug and device development. Prior to joining ReNeuron, Dr. Beckman was the chief medical officer of several innovative biotech and device firms, including Clearside, Ophthotech and Neurotech. Prior to that, he had leadership roles at Alcon, Lux Bio, Becton Dickinson and Allergan. Dr. Beckman will be based in ReNeuron's recently established US office in Boston, MA, where he will lead the company's clinical and medical affairs team.